Weight loss using medications such as Semaglutide and Tirzepatide offers targeted support for individuals struggling to achieve weight loss through traditional methods alone. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, and Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, are FDA-approved medications that work by regulating appetite, slowing stomach emptying, and promoting feelings of fullness.

These medications are typically prescribed as part of a comprehensive weight loss program that includes dietary modifications and increased physical activity. However, it's important to recognize that these medications are not suitable for everyone and may have potential side effects, including gastrointestinal issues and hypoglycemia.

The timing of when you start seeing results from weight loss medications like Semaglutide and Tirzepatide can vary among individuals. However, many users may begin to notice changes within the first few weeks to months of starting treatment. It's essential to remember that weight loss is a gradual process, and individual results may vary based on factors such as starting weight, adherence to medication and lifestyle changes, metabolism, and overall health status.

Some individuals may achieve their weight loss goals within a few months of starting medication and may choose to discontinue the medication once they reach their target weight. However, for others, especially those with obesity or related health conditions, long-term medication use may be recommended to help maintain weight loss and improve metabolic health.